sections button arrow
Recipients of the Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in Partnership with Pelotonia and AACR

Research and Grants Administration

tooltip iconThe 2022-2023 recipients of the Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in Partnership with Pelotonia and AACR, were honored during the AACR Annual Meeting 2023.

Investing in the Future of Cancer Research

For 30 years, the AACR Grants Program has advanced the frontiers of cancer science by investing in promising basic, translational, and clinical researchers at all career levels. Through the generous support of its partners—including nonprofit organizations, foundations, and pharmaceutical companies—the AACR has distributed more than 1,000 grants totaling nearly $530 million since 1993 to foster innovative cancer research and accelerate progress toward improved patient outcomes.

2023 AACR Grant Recipients


The AACR’s grant portfolio expanded significantly in 2023 with a host of new supporters and new funding mechanisms:

  • AACR-StacheStrong Glioblastoma Research Fellowship. The AACR welcomed StacheStrong as a new funding partner in 2023. The fellowship supports a postdoctoral or clinical research fellow conducting brain cancer research and enables them to establish a successful career path in this field.
  • AACR-D-Team Sarcoma Research Fellowships. Funded by a team of 92 friends and family members of cancer survivor Darcy Horn—all of whom participated in the 2022 AACR Philadelphia Marathon weekend to support cancer research—these two new grants support a postdoctoral or clinical research fellow conducting translational or clinical sarcoma research.
  • AACR-Maximizing Opportunity for New Advancements in Research in Cancer (MONARCA) Grants for Latin America. Three grants were awarded in May to support early–career investigators in Latin America to establish a successful career path in cancer research. The grants are part of an AACR initiative to alleviate the public health burden of cancer in Latin America by developing a pipeline of talented investigators in the region.
  • AACR-Sontag Foundation Brain Cancer Research Fellowship. The Sontag Foundation also became an AACR grant supporter for the first time in 2023. This new fellowship funds a postdoctoral or clinical research fellow conducting brain cancer research, supporting them as they establish a career in the field.
  • Lustgarten Foundation–Swim Across America–AACR Pancreatic Cancer Early Detection Research Grant. This new grant supports innovative research aimed at advancing early detection and interception strategies for pancreatic cancer.
  • AACR-Pediatric Brain Tumor Foundation Medulloblastoma Research Fellowship. This new grant from a previous AACR funder supports a postdoctoral or clinical research fellow conducting brain cancer research.
  • AACR-Johnson & Johnson Lung Cancer Initiative Clinical Oncology Research Training Fellowship. Johnson & Johnson is a long-standing supporter of AACR grants. This new funding mechanism—which is focused on academic clinicians who are female or are members of an underrepresented group—provides recipients with a unique opportunity to train in drug development in an industry setting.
  • AACR-Debbie’s Dream Foundation Innovation and Discovery Grant. This new grant supports basic, translational, and/or clinical research projects that examine important and druggable novel targets and/or biomarkers that are relevant for gastric cancer.
  • Victoria’s Secret Global Fund for Women's Cancers Career Development Award, in Partnership with Pelotonia & AACR. In 2022, the first year of this new funding partnership, a total of five career development awards were presented to early–career women scientists. In 2023, five new grants supported mid–career women investigators, funding innovative research projects in breast and gynecologic cancers that focus on eliminating cancer health disparities.
Madelyn Espinosa-Cotton, PhD, AACR Grantee

The AACR and Stand Up To Cancer: A Partnership for Patients

In 2023, Stand Up To Cancer (SU2C) marked its 15th year of accelerating the delivery of new therapies to cancer patients by supporting collaboration and innovation in translational cancer research. The AACR has proudly served as SU2C’s Scientific Partner throughout those 15 years, providing expert peer review, scientific oversight, policy guidance, communications, and grants administration to ensure that SU2C’s groundbreaking funding models deliver outstanding results.


In November, the AACR and the Entertainment Industry Foundation signed an agreement to formally extend the AACR’s relationship with SU2C. The AACR will continue to serve as the Scientific Partner for SU2C, and in that role the AACR will have exclusive responsibility for administering the SU2C Grants Program.


On August 19, with the support of the AACR, SU2C produced its eighth biennial telecast featuring entertainers from the worlds of film, television, and music. The broadcast—which showcased the remarkable progress made by SU2C–funded scientists and moving stories of patients who have benefited from that progress—raised more than $60 million in pledges to support SU2C’s innovative research programs.


Collaboration and accountability are critical elements of the SU2C funding model. By bringing together stakeholders on a regular basis, SU2C and the AACR monitor the progress of funded research projects and foster connections that can lead to new discoveries. In January, the SU2C community convened its first in-person Scientific Summit since the pandemic. Grantees, leaders, Scientific Advisors, and donors gathered in San Diego to share data, celebrate successes, and explore new opportunities to work together to benefit patients with cancer.

Participants in the Stand Up To Cancer Scientific Summit 2023
arrow to previous page Science and Education

Science and Education

Policy and Advocacy

arrow to next page Policy and Advocacy